Daunorubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Fluphenazine Manufacturers of Fluphenazine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Fluphenazine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 30 to 45 mg/sq.meter38 (37.5)24 hourlyIVFor 3 Days, (Courses may be repeated after 3 to 6 weeks). Paedriatic Dosage (20kg) 25 mg/sq.meter46 (46)As recommended.Intra VenousOnce a week.For acute lyphoblastic leukaemia in combination regiments. Neonatal Dosage (3kg) 1 mg/sq.meter2 (2)As recommended.Intra VenousAs Required High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Fluphenazine Back to top Manufacturers of Daunorubicin (HCl) in Pakistan A.J.Mirza Al-Habib Pfizer Pharmedic Scharper Back to top Previous Drug Generic - Next Drug Generic
Daunorubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Fluphenazine Manufacturers of Fluphenazine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Fluphenazine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 30 to 45 mg/sq.meter38 (37.5)24 hourlyIVFor 3 Days, (Courses may be repeated after 3 to 6 weeks). Paedriatic Dosage (20kg) 25 mg/sq.meter46 (46)As recommended.Intra VenousOnce a week.For acute lyphoblastic leukaemia in combination regiments. Neonatal Dosage (3kg) 1 mg/sq.meter2 (2)As recommended.Intra VenousAs Required High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Fluphenazine Back to top Manufacturers of Daunorubicin (HCl) in Pakistan A.J.Mirza Al-Habib Pfizer Pharmedic Scharper Back to top Previous Drug Generic - Next Drug Generic